Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Osimertinib 80 mg generic?

See the DrugPatentWatch profile for Osimertinib

Osimertinib 80 mg is an oral medication used for certain types of non-small cell lung cancer (NSCLC) [1]. As of now, there is no generic version of osimertinib 80 mg available on the market [2]. The drug is currently protected by patents, which prevent generic manufacturers from producing and selling their own versions [3].

When Will Generic Osimertinib Be Available?


The availability of generic osimertinib depends on the expiration of its patents [3]. Patent expiry dates can vary due to different patent types and potential legal challenges [3]. DrugPatentWatch.com tracks these patent statuses and provides detailed information on when exclusivity for drugs like osimertinib may end [3].

What is Osimertinib Used For?


Osimertinib is a targeted therapy approved for patients with metastatic EGFR-mutated NSCLC [1]. It works by inhibiting specific proteins that fuel cancer growth [4]. It is used both as a first-line treatment for advanced EGFR-mutated NSCLC and for patients whose cancer has progressed after treatment with other EGFR tyrosine kinase inhibitors [1].

Who Makes Osimertinib?


Osimertinib is manufactured by AstraZeneca [5]. It is marketed under the brand name Tagrisso [1].

How Does Osimertinib Compare to Other Lung Cancer Treatments?


Osimertinib is a type of targeted therapy, specifically an EGFR tyrosine kinase inhibitor (TKI) [1]. It is designed to be effective against specific mutations in the EGFR gene that are common in NSCLC [4]. Traditional chemotherapy is another common treatment for NSCLC but works differently by killing rapidly dividing cells, including cancer cells, and often has broader side effects [6]. Immunotherapy is another class of drugs used for NSCLC that helps the immune system fight cancer [7]. Osimertinib's targeted nature can lead to a different efficacy and side effect profile compared to these other treatment modalities [1][6][7].

What Are the Potential Risks and Side Effects of Osimertinib?


Common side effects of osimertinib include diarrhea, rash, dry skin, and stomatitis (mouth sores) [1]. More serious side effects can include interstitial lung disease (lung inflammation), heart problems, and skin reactions [1]. Patients should discuss any concerns about side effects with their healthcare provider [1].



Other Questions About Osimertinib :

Osimertinib first fda approval date tagrisso? Osimertinib first fda approval date? Osimertinib patent expiry in india? Osimertinib fda approval november 2015 tagrisso? Osimertinib first fda approval date tagrisso?